Condition
GFAP
Total Trials
4
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting3
Enrolling By Invitation1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07312994Recruiting
Analysis of NfL and GFAP in Different Dietary Patterns
NCT07133113Recruiting
Medium-term Effects of Treatments in Autoimmune Encephalitis
NCT07025122Enrolling By Invitation
Fatigue in Multiple Sclerosis and Its Relationship to Inflammatory and Neurodegenerative Markers of the Disease
NCT06733714Not ApplicableRecruiting
Association of Transcranial Alternating Current Stimulation with Digital Cognitive Training for Cognitive Remediation in Older Adults
Showing all 4 trials